α1-antitrypsin deficiency

Lancet

Volumn 365, Issue 9478, 2005, Pages 2225-2236

  Stoller, James K ^a   Aboussouan, Loutfi S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; BRONCHODILATING AGENT; LEUKOCYTE ELASTASE; VACCINE;

ALLELE; ALPHA 1 ANTITRYPSIN DEFICIENCY; ANAPHYLAXIS; ANXIETY; AUTOSOMAL DOMINANT DISORDER; CHILL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DIZZINESS; DRUG COST; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FATIGUE; FEVER; FLUSHING; GENE MUTATION; HEADACHE; HEALTH CARE COST; HUMAN; HYPOTENSION; INFECTION RATE; LIVER CELL; LIVER DISEASE; LUNG EMPHYSEMA; LUNG FUNCTION; MUSCLE CRAMP; NAUSEA; PAIN; PANNICULITIS; PLASMA; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PRURITUS; RASH; SIDE EFFECT; SURVIVAL RATE; TACHYCARDIA; THORAX PAIN; URTICARIA; VASCULITIS; VIRAL GENE DELIVERY SYSTEM; VOMITING; WHEEZING; GENETICS; PATHOPHYSIOLOGY; REVIEW;

ALPHA 1-ANTITRYPSIN DEFICIENCY; HUMANS;

EID: 20744450475     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)66781-5     Document Type: Conference Paper

References (114)

1. MB Strauss Familiar medical quotations 1968 Little Brown and Co Boston
2. 1 antitrypsin and to Carl-Bertil Laurell COPD 1 2004 71 84
3. C-B Laurell, A Eriksson The electrophoretic alpha 1-globulin pattern of serum in alpha 1-antitrypsin deficiency Scand J Clin Lab Invest 15 1963 132 40
4. M Lethbridge-Çejku, JS Schiller, L Bernadel Vital and Health Statistics, series 10, number222 summary health statistics for US adults - National Health Interview Survey, 2002 2004 National Center for Health Statistics Hyattsville http://www.cdc.gov/nchs/data/series/sr_10/sr10_222.pdf (accessed April 18, 2005)
5. J Lieberman, B Winter, A Sastre Alpha 1-antitrypsin Pi-types in 965 COPD patients Chest 89 1986 370 73
6. FJ De Serres, I Blanco, E Fernandez-Bustillo Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America Clin Genet 64 2003 382 97
7. FJ de Serres Worldwide racial and ethnic distribution of alpha(1)-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys Chest 122 2002 1818 29
8. M Luisetti, N Seersholm Alpha1-antitrypsin deficiency, 1: epidemiology of alpha 1-antitrypsin deficiency Thorax 59 2004 164 69
9. ML O'Brien, NR Buist, WH Murphey Neonatal screening for alpha 1-antitrypsin deficiency J Pediatr 92 1978 1006 10
10. EK Silverman, JP Miletich, JA Pierce Alpha-1-antitrypsin deficiency: high prevalence in the St Louis area determined by direct population screening Am Rev Respir Dis 140 1989 961 66
11. WC Spence, JE Morris, K Pass, PD Murphy Molecular confirmation of alpha 1-antitrypsin genotypes in newborn dried blood specimens Biochem Med Metab Biol 50 1993 233 40
12. T Sveger Liver disease in alpha 1-antitrypsin deficiency detected by screening of 200,000 infants N Engl J Med 294 1976 1316 21
13. US Census Bureau 2000 census of population and housing: summary population and housing characteristics, PHC-1-1 2002 US Census Bureau Washington, DC
14. S Eriksson A 30-year perspective on alpha 1-antitrypsin deficiency Chest 110 6 suppl 1996 237S 42S
15. JE Gadek, RG Crystal Alpha 1-antitrypsin deficiency JB Stanbury JB Wyngaarden DS Frederickson The metabolic basis of inherited disease 1983 McGraw-Hill New York 1450 67
16. MJ Tobin, PJ Cook, DC Hutchison Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z - a survey by the British Thoracic Association Br J Dis Chest 77 1983 14 27
17. JK Stoller, P Smith, P Yang, J Spray Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey Cleve Clin J Med 61 1994 461 67
18. MA Campos, R Sandhaus Quality of life among patients with alpha-1 antitrypsin deficiency on augmentation therapy Am J Respir Crit Care Med 169 2004 A517
19. Stoller JK, Sandhaus RA, Turino GM, Dickson R, Rodger K, Strange C. Delay in diagnosis of alpha-1 antitrypsin deficiency: a continuing problem. Chest (in press)
20. DL DeMeo, EK Silverman Alpha 1-antitrypsin deficiency, 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk Thorax 59 2004 259 64
21. MC Owen, SO Brennan, JH Lewis, RW Carrell Mutation of antitrypsin to antithrombin: alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder N Engl J Med 309 1983 694 98
22. DA Lomas, R Mahadeva Alpha 1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy J Clin Invest 110 2002 1585 90
23. RR Kopito, D Ron Conformational disease Nat Cell Biol 2 2000 E207 09
24. AA Stecenko, KL Brigham Gene therapy progress and prospects: alpha-1 antitrypsin Gene Ther 10 2003 95 99
25. K Beatty, J Bieth, J Travis Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1- antichymotrypsin J Biol Chem 255 1980 3931 34
26. R Mahadeva, SD Shapiro Chronic obstructive pulmonary disease 3: experimental animal models of pulmonary emphysema Thorax 57 2002 908 14
27. SD Shapiro Proteinases in chronic obstructive pulmonary disease Biochem Soc Trans 30 2002 98 102
28. JA Huntington, RJ Read, RW Carrell Structure of a serpin-protease complex shows inhibition by deformation Nature 407 2000 923 26
29. TR Dafforn, R Mahadeva, PR Elliott, P Sivasothy, DA Lomas A kinetic mechanism for the polymerization of alpha 1-antitrypsin J Biol Chem 274 1999 9548 55
30. GL Devlin, MK Chow, GJ Howlett, SP Bottomley Acid denaturation of alpha1-antitrypsin: characterization of a novel mechanism of serpin polymerization J Mol Biol 324 2002 859 70
31. P Sivasothy, TR Dafforn, PG Gettins, DA Lomas Pathogenic alpha 1-antitrypsin polymers are formed by reactive loop-beta-sheet A linkage J Biol Chem 275 2000 33663 68
32. DA Lomas, DL Evans, JT Finch, RW Carrell The mechanism of Z alpha 1-antitrypsin accumulation in the liver Nature 357 1992 605 07
33. A Janoff Elastases and emphysema: current assessment of the protease-antiprotease hypothesis Am Rev Respir Dis 132 1985 417 33
34. F Ogushi, GA Fells, RC Hubbard, SD Straus, RG Crystal Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase J Clin Invest 80 1987 1366 74
35. PR Elliott, D Bilton, DA Lomas Lung polymers in Z alpha1-antitrypsin deficiency-related emphysema Am J Respir Cell Mol Biol 18 1998 670 74
36. AT Mulgrew, CC Taggart, MW Lawless Z alpha1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant Chest 125 2004 1952 57
37. JS Parmar, R Mahadeva, BJ Reed Polymers of alpha(1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema Am J Respir Cell Mol Biol 26 2002 723 30
38. RA Stockley, DL Bayley, I Unsal, LJ Dowson The effect of augmentation therapy on bronchial inflammation in alpha 1 antitrypsin deficiency Am J Respir Crit Care Med 165 2002 1494 98
39. LT Spencer, G Paone, PM Krein, FN Rouhani, J Rivera-Nieves, ML Brantly Role of human neutrophil peptides in lung inflammation associated with alpha 1-antitrypsin deficiency Am J Physiol Lung Cell Mol Physiol 286 2004 L514 20
40. R Aldonyte, L Jansson, S Janciauskiene Concentration-dependent effects of native and polymerised alpha1-antitrypsin on primary human monocytes, in vitro BMC Cell Biol 5 2004 11
41. S Janciauskiene, S Larsson, P Larsson, R Virtala, L Jansson, T Stevens Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by alpha1-antitrypsin Biochem Biophys Res Commun 321 2004 592 600
42. DA Lomas, JT Finch, K Seyama, T Nukiwa, RW Carrell Alpha 1-antitrypsin Siiyama (Ser53?Phe): further evidence for intracellular loop-sheet polymerization J Biol Chem 268 1993 15333 35
43. 52-deleted) forms loop-sheet polymers in vivo: evidence for the C sheet mechanism of polymerization J Biol Chem 270 1995 16864 70
44. D Qu, JH Teckman, S Omura, DH Perlmutter Degradation of a mutant secretory protein, alpha1-antitrypsin Z, in the endoplasmic reticulum requires proteasome activity J Biol Chem 271 1996 22791 95
45. NY Marcus, DH Perlmutter Glucosidase and mannosidase inhibitors mediate increased secretion of mutant alpha 1 antitrypsin Z J Biol Chem 275 2000 1987 92
46. Y Wu, MT Swulius, KW Moremen, RN Sifers Elucidation of the molecular logic by which misfolded alpha 1-antitrypsin is preferentially selected for degradation Proc Natl Acad Sci USA 100 2003 8229 34
47. RN Sifers Cell biology: protein degradation unlocked Science 299 2003 1330 31
48. SS Wu, JP de Chadarevian, L McPhaul, NE Riley, FW van Leeuwen, SW French Coexpression and accumulation of ubiquitin +1 and ZZ proteins in livers of children with alpha(1)-antitrypsin deficiency Pediatr Dev Pathol 5 2002 293 98
49. JF Tomashefski Jr, RG Crystal, HP Wiedemann, E Mascha, JK Stoller The bronchopulmonary pathology of alpha-1 antitrypsin (AAT) deficiency: findings of the death review committee of the national registry for individuals with severe deficiency of alpha-1 antitrypsin Hum Pathol 35 2004 1452 61
50. S Eriksson, J Carlson, R Velez Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency N Engl J Med 314 1986 736 39
51. M Hussain, G Mieli-Vergani, AP Mowat Alpha 1-antitrypsin deficiency and liver disease: clinical presentation, diagnosis and treatment J Inherit Metab Dis 14 1991 497 511
52. J McBean, A Sable, J Maude, L Robinson-Bostom Alpha 1-antitrypsin deficiency panniculitis Cutis 71 2003 205 09
53. AN Elzouki, M Segalmark, P Mazodier, S Eriksson Wegener's granulomatosis in a patient with severe PiZZ alpha 1-antitrypsin deficiency QJM 89 1996 877
54. AN Elzouki, S Eriksson, R Lofberg, L Nassberger, J Wieslander, S Lindgren The prevalence and clinical significance of alpha 1-antitrypsin deficiency (PiZ) and ANCA specificities (proteinase 3, BPI) in patients with ulcerative colitis Inflamm Bowel Dis 5 1999 246 52
55. A Montanelli, E Mainardi, L Pini, L Corda, V Grassi Alpha-1-antitrypsin deficiency and nephropathy Nephron 90 2002 114 15
56. RF Pons, F Casafont, dL Rodriguez, G San Miguel, E Artinano, J Cagigas Could alpha 1 antitrypsin deficiency have any role in the development of celiac sprue after gastric operations? J Clin Gastroenterol 8 1986 559 61
57. Z Sun, P Yang Role of imbalance between neutrophil elastase and α1-antitrypsin in cancer development and progression Lancet Oncol 5 2004 182 90
58. AN Elzouki, AA Ryden, T Lanne, B Sonesson, S Eriksson Is there a relationship between abdominal aortic aneurysms and alpha1-antitrypsin deficiency (PiZ)? Eur J Vasc Endovasc Surg 17 1999 149 54
59. A Bofinger, C Hawley, P Fisher, N Daunt, M Stowasser, R Gordon Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia J Hum Hypertens 14 2000 91 94
60. AA Rabassa, MR Schwartz, A Ertan Alpha 1-antitrypsin deficiency and chronic pancreatitis Dig Dis Sci 40 1995 1997 2001
61. ML Brantly, LD Paul, BH Miller, RT Falk, M Wu, RG Crystal Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms Am Rev Respir Dis 138 1988 327 36
62. P Gishen, AJ Saunders, MJ Tobin, DC Hutchison Alpha 1-antitrypsin deficiency: the radiological features of pulmonary emphysema in subjects of Pi type Z and Pi type SZ: a survey by the British Thoracic Association Clin Radiol 33 1982 371 77
63. NG McElvaney, JK Stoller, AS Buist Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency Chest 111 1997 394 403
64. DG Parr, BC Stoel, J Stolk, RA Stockley Pattern of emphysema distribution in alpha 1-antitrypsin deficiency influences lung function impairment Am J Respir Crit Care Med 170 2004 1172 78
65. NR Anthonisen, EC Wright Bronchodilator response in chronic obstructive pulmonary disease Am Rev Respir Dis 133 1986 814 19
66. C Larsson Natural history and life expectancy in severe alpha 1-antitrypsin deficiency, Pi Z Acta Med Scand 204 1978 345 51
67. RJ Fallat Reactive airways disease and alpha 1-antitrypsin deficiency RG Crystal Alpha 1-antitrypsin deficiency: biology, pathogenesis, clinical manifestations, therapy 1996 Marcel Dekker New York 259 79
68. A Cuvelier, JF Muir, MF Hellot Distribution of alpha(1)-antitrypsin alleles in patients with bronchiectasis Chest 117 2000 415 19
69. American Thoracic Society/European Respiratory Society American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency Am J Respir Crit Care Med 168 2003 818 900
70. M Brantly Alpha-1 antitrypsin genotypes and phenotypes RG Crystal Alpha-1 antitrypsin deficiency: biology, pathogenesis, clinical manifestations, therapy 1996 Marcel Dekker New York 45 59
71. GM Turino, AF Barker, ML Brantly Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency Am J Respir Crit Care Med 154 1996 1718 25
72. S Eriksson Alpha 1-antitrypsin deficiency and liver cirrhosis in adults: an analysis of 35 Swedish autopsied cases Acta Med Scand 221 1987 461 67
73. J Warter, D Storck, E Grosshans, P Metais, JL Kuntz, T Klumpp [Weber-Christian syndrome associated with an alpha-1 antitrypsin deficiency. Familial investigation] Ann Med Interne (Paris) 123 1972 877 82
74. BK Edmonds, JA Hodge, RL Rietschel Alpha 1-antitrypsin deficiency-associated panniculitis: case report and review of the literature Pediatr Dermatol 8 1991 296 99
75. WJ Chng, CA Henderson Suppurative panniculitis associated with alpha 1-antitrypsin deficiency (PiSZ phenotype) treated with doxycycline Br J Dermatol 144 2001 1282 83
76. AR Pinto, LS Maciel, F Carneiro, C Resende, FC Chaves, AF Freitas Systemic nodular panniculitis in a patient with alpha-1 antitrypsin deficiency (PiSS phenotype) Clin Exp Dermatol 18 1993 154 55
77. F Loche, C Tremeau-Martinage, G Laplanche, P Massip, J Bazex Panniculitis revealing qualitative alpha 1 antitrypsin deficiency (MS variant) Eur J Dermatol 9 1999 565 67
78. K O'Riordan, A Blei, MS Rao, M Abecassis alpha 1-antitrypsin deficiency-associated panniculitis: resolution with intravenous alpha 1-antitrypsin administration and liver transplantation Transplantation 63 1997 480 82
79. MM Chowdhury, EJ Williams, JS Morris Severe panniculitis caused by homozygous ZZ alpha 1-antitrypsin deficiency treated successfully with human purified enzyme (Prolastin) Br J Dermatol 147 2002 1258 61
80. VL Esnault, A Testa, M Audrain Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis Kidney Int 43 1993 1329 32
81. Alpha-1-Antitrypsin Deficiency Registry Study Group Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin Am J Respir Crit Care Med 158 1998 49 59
82. DC Hutchison, MJ Tobin, D Cooper Longitudinal studies in alpha-1 antitrypsin deficiency: a survey by the British Thoracic Society JC Taylor C Mittman Pulmonary emphysema and proteolysis 1987 Academic Press Orlando
83. 1-antitrypsin deficiency Lancet 1 1985 152 54
84. E Piitulainen, S Eriksson Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ) Eur Respir J 13 1999 247 51
85. N Seersholm, M Wencker, N Banik Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Eur Respir J 10 1997 2260 63
86. MC Wu, S Eriksson Lung function, smoking and survival in severe alpha 1-antitrypsin deficiency, PiZZ J Clin Epidemiol 41 1988 1157 65
87. N Seersholm, A Kok-Jensen, A Dirksen Decline in FEV1 among patients with severe hereditary alpha 1-antitrypsin deficiency type PiZ Am J Respir Crit Care Med 152 1995 1922 25
88. PA Dawkins, LJ Dowson, PJ Guest, RA Stockley Predictors of mortality in alpha 1-antitrypsin deficiency Thorax 58 2003 1020 26
89. N Seersholm, A Dirksen, A Kok-Jensen Airways obstruction and two year survival in patients with severe alpha 1-antitrypsin deficiency Eur Respir J 7 1994 1985 87
90. JK Stoller Clinical practice: acute exacerbations of chronic obstructive pulmonary disease N Engl J Med 346 2002 988 94
91. ER Sutherland, RM Cherniack Management of chronic obstructive pulmonary disease N Engl J Med 350 2004 2689 97
92. A Fishman, F Martinez, K Naunheim A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema N Engl J Med 348 2003 2059 73
93. M Tutic, KE Bloch, D Lardinois, T Brack, EW Russi, W Weder Long-term results after lung volume reduction surgery in patients with alpha 1-antitrypsin deficiency J Thorac Cardiovasc Surg 128 2004 408 13
94. MD Wewers, MA Casolaro, SE Sellers Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema N Engl J Med 316 1987 1055 62
95. AF Barker, I Iwata-Morgan, L Oveson, R Roussel Pharmacokinetic study of alpha 1-antitrypsin infusion in alpha1-antitrypsin deficiency Chest 112 1997 607 13
96. RC Hubbard, S Sellers, D Czerski, L Stephens, RG Crystal Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency JAMA 260 1988 1259 64
97. A Dirksen, JH Dijkman, F Madsen A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy Am J Respir Crit Care Med 160 1999 1468 72
98. DJ Gottlieb, M Luisetti, PJ Stone Short-term supplementation therapy does not affect elastin degradation in severe alpha(1)-antitrypsin deficiency Am J Respir Crit Care Med 162 2000 2069 72
99. M Wencker, B Fuhrmann, N Banik, N Konietzko Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor Chest 119 2001 737 44
100. J Lieberman Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data Chest 118 2000 1480 85
101. PJ Stone, TA Morris III, C Franzblau, GL Snider Preliminary evidence that augmentation therapy diminishes degradation of cross-linked elastin in alpha-1-antitrypsin-deficient humans Respiration 62 1995 76 79
102. RT Abboud, GT Ford, KR Chapman Alpha 1-antitrypsin deficiency: a position statement of the Canadian Thoracic Society Can Respir J 8 2001 81 88
103. JK Stoller, R Fallat, MD Schluchter Augmentation therapy with alpha-1 antitrypsin: patterns of use and adverse events Chest 123 2003 1425 34
104. M Wencker, N Banik, R Buhl, R Seidel, N Konietzko Long-term treatment of alpha 1-antitrypsin deficiency-related pulmonary emphysema with human alpha 1-antitrypsin Eur Respir J 11 1998 428 33
105. JK Stoller, F Rouhani, M Brantly Biochemical efficacy and safety of a new pooled human plasma alpha(1)-antitrypsin, Respitin Chest 122 2002 66 74
106. SA Alkins, P O'Malley Should health-care systems pay for replacement therapy in patients with alpha(1)-antitrypsin deficiency? A critical review and cost-effectiveness analysis Chest 117 2000 875 80
107. TR Gildea, KM Shermock, ME Singer, JK Stoller Cost-effectiveness analysis of augmentation therapy for severe alpha-1 antitrypsin deficiency Am J Respir Crit Care Med 167 2003 1387 92
108. JW Hay, ED Robin Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary disease Am J Public Health 81 1991 427 33
109. The Alpha-1 Antitrypsin Deficiency Registry Study Group A registry of patients with severe deficiency of alpha 1-antitrypsin: design and methods Chest 106 1994 1223 32
110. TR Flotte, ML Brantly, LT Spencer Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults Hum Gene Ther 15 2004 93 128
111. H Parfrey, TR Dafforn, D Belorgey, DA Lomas, R Mahadeva Inhibiting polymerization: new therapeutic strategies for Z alpha 1 antitrypsin-related emphysema Am J Respir Cell Mol Biol 31 2004 133 39
112. A Zhou, PE Stein, JA Huntington, P Sivasothy, DA Lomas, RW Carrell How small peptides block and reverse serpin polymerisation J Mol Biol 342 2004 931 41
113. JA Burrows, LK Willis, DH Perlmutter Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: a potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency Proc Natl Acad Sci USA 97 2000 1796 801
114. AM Cantin, DE Woods, D Cloutier, EK Dufour, R Leduc Polyethylene glycol conjugation at Cys232 prolongs the half-life of alpha 1 proteinase inhibitor Am J Respir Cell Mol Biol 27 2002 659 65